Spire Wealth Management - TONIX PHARMACEUTICALS HLDG C ownership

Back to all holdings Add to watchlist

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Spire Wealth Management ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$2,0000.0%6,7000.0%0.00%–
Q4 2021$2,000
-77.8%
6,700
-55.3%
0.00%–
Q3 2021$9,000
-47.1%
15,0000.0%0.00%–
Q2 2021$17,000
-10.5%
15,0000.0%0.00%
-100.0%
Q1 2021$19,000–15,000–0.00%–
 Download
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2022
NameSharesValueWeighting ↓
IFP Advisors, Inc 200$1,0000.00%
Sterling Investment Advisors, Ltd. 4$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders